Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(18):1403-1404; doi:10.1093/jnci/djh281
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Umar, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Umar, A.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

RESPONSE: Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability

Asad Umar

Correspondence to: Asad Umar, PhD, DVM, National Cancer Institute, National Institutes of Health, 6130 Executive Blvd., EPN 2141, Bethesda, MD 20892 (e-mail: asad.umar@nih.gov)

The first 10% of the full text of this article appears below.

Dr. Laghi proposes that all colorectal cancers be screened for microsatellite instability (MSI) using BAT26 as a marker rather than selecting patients based on family history for screening with the National Cancer Institute (NCI) panel of markers, as proposed in the revised Bethesda Guidelines (Table 1) (1). This issue—that using just one MSI . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Luigi Laghi, Paolo Bianchi, Massimo Roncalli, and Alberto Malesci
J Natl Cancer Inst 2004 96: 1402-1403. [Extract] [Full Text] [PDF]